华润微 reported revenue of ¥6.13B for the period ended 2026-06-30, +17.4% year on year. Net income was ¥0.67B, a 10.9% net margin on a 26.6% gross margin. The largest revenue line is 产品与方案 at 57% of the total. Free cash flow for the period was ¥0.45B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.13B | +17.4% |
| Gross profit | ¥1.63B | — |
| Operating income | ¥0.82B | — |
| Net income | ¥0.67B | +139.0% |
| Gross margin | 26.6% | Net margin 10.9% |
| Revenue Q/Q | +14.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 产品与方案 | ¥3.49B | 57.0% |
| 制造与服务 | ¥2.50B | 40.8% |
| 其他(补充) | ¥0.13B | 2.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.50B | 73.4% |
| R&D | ¥0.53B | 8.6% |
| SG&A | ¥0.37B | 6.1% |
| Tax & other | ¥0.16B | 2.6% |
| Item | Amount |
|---|---|
| Total assets | ¥31.20B |
| Total liabilities | ¥5.66B |
| Shareholders' equity | ¥25.54B |
| Equity / assets | 81.9% |
| Operating cash flow | ¥0.76B |
| Capital expenditure | ¥0.31B |
| Free cash flow | ¥0.45B |
| Cash conversion (OCF / net income) | 209% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
阿特斯 ・ 百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies